Raches Ella

Employment

Employment history is unavailable.

Education

• Sri Ramachandra Medical College and Research Institute MD
• Emory University MS
• Johns Hopkins University Postdoc

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
  The Lancet 2021 DOI: 10.1016/s0140-6736(21)02000-6
  +Save
• Persisting antibody responses to Vi polysaccharide–tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination
  Vaccine 2021 DOI: 10.1016/j.vaccine.2021.07.073
  +Save
• Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B 1.1.7 variant of SARS-CoV-2.
  Journal of travel medicine 2021 DOI: 10.1093/jtm/taab051
  +Save
• Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation.
  iScience 2021 DOI: 10.1016/j.isci.2021.102298
  +Save
• Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
  Nature Communications 2021 DOI: 10.1038/s41467-021-21639-w
  +Save
• Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.
  The Lancet. Infectious diseases 2021 DOI: 10.1016/s1473-3099(20)30942-7
  +Save
• Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model.
  iScience 2021 DOI: 10.1016/j.isci.2021.102054
  +Save
• Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report
  2020 DOI: 10.1101/2020.12.21.20248643
  +Save
• Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine-BBV152: A Phase 1, Double-Blind, Randomised Control Trial
  2020 DOI: 10.2139/ssrn.3747047
  +Save
• Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine
  The Journal of Infectious Diseases 2019 DOI: 10.1093/infdis/jiz672
  +Save